|
(b)(4).Date sent to the fda: 3/26/2020.A manufacturing record evaluation was performed for the finished device lot number: pb2133, and no non-conformances related to the reported complaint condition were identified.Additional h3 investigation summary: it was reported performance breakage needle.An empty opened foil, a paper lid, a dispensed needle/suture piece and an empty howi tray of product code: vcp344, lot#: pb2133 were received for evaluation.During the visual inspection of the sample, the swage and attachment area were noted to be as expected.No needle breakage or marks could be observed.The suture end was noted detached due to stress applied to strand; however, no body fluids were present.Also, the needle was tested by resistance test to needle and met the requirements.The manufacturing records were reviewed, and the manufacturing/packaging criteria were met prior to the release of this batch.Per the condition of the sample received, no performance breakage needle were found.
|